Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialisation: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels.
| Last: | $0.0076 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0076 |
| Close: | $0.0076 |
| High: | $0.0076 |
| Low: | $0.0076 |
| Volume: | 49,000 |
| Last Trade Date Time: | 08/12/2025 09:57:55 am |
| Market Cap: | $14,141,413 |
|---|---|
| Float: | 159,372,627 |
| Insiders Ownership: | 2.6% |
| Institutions: | 38 |
| Short Percent: | N/A |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Website: | https://www.vericidx.com |
| Country: | GB |
| City: | Cardiff |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Verici Dx (OTCMKTS: VRCDF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
